Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CASP3 | P42574 | 2/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.32 |
| ▸ | APAF1 | O14727 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12325034 | 1.00 | PDK2 (0.40) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL29512073 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL29351177 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL17070108 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL18906597 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL14520993 | 0.97 | PDK2 (0.38) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL2431947 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL15473730 | 0.97 | PDK2 (0.41) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL14520994 | 0.94 | PDK2 (0.42) | PDK2LMNANPSR1ESR1ESR2 | |
| SCHEMBL15910171 | 0.94 | ACHE (0.38) | PDK2LMNANPSR1ACHEHSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070077450-A1 | Conjugated compounds containing triarylamine structural elements, and their use | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2007-04-05 | — | — | US | disclosed |
| US-20070077450-A1 | Conjugated compounds containing triarylamine structural elements, and their use | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070077450-A1 | Conjugated compounds containing triarylamine structural elements, and their use | TIMM9, DCX, INMT | PDK2 3526/4885LMNA 2503/4885NPSR1 1894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.